Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.

RTTNews | 602 days ago

Pfizer Receives All Required Regulatory Approvals To Complete Seagen Acquisition

Pfizer Inc. (PFE) announced Tuesday that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired December 11, 2023, with respect to Pfizer's pending acquisition of Seagen Inc. (SGEN).

RTTNews | 604 days ago

Merck Says Phase 3 KEYNOTE-A39/EV-302 Trial Meets Dual Primary Endpoints

Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Friday positive topline results from the Phase 3 KEYNOTE-A39 trial, which was conducted in collaboration with Seagen Inc. (SGEN) and Astellas Pharma Inc. (ALPMY.PK, ALPMY).

RTTNews | 685 days ago

LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical Officer

Immuno-oncology company LAVA Therapeutics N.V. (LVTX) announced Monday that Dr. Charles Morris has joined LAVA as chief medical officer effective February 6, 2023. Dr. Morris will replace Benjamin Winograd.

RTTNews | 913 days ago

Seagen Appoints David Epstein As New CEO

Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors.

RTTNews | 1001 days ago

Australian Market Notably Lower

The Australian stock market is trading notably lower on Friday, extending the slight losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,800 level, with weakness in energy, financial and technology stocks partially offset by gains in mining stocks.

RTTNews | 12 minutes ago

Rally May Stall For China Stock Market

The China stock market has tracked higher in four straight sessions, gathering almost 80 points or 2.4 percent along the way. The Shanghai Composite Index now sits just beneath the 3,640-point plateau although it may run out of steam on Friday.

RTTNews | 18 minutes ago

Taiwan Stock Market May Hand Back Thursday's Gains

The Taiwan stock market has moved higher in two of three trading days since the end of the two-day losing streak in which it had slipped more than 270 points or 1.2 percent. The Taiwan Stock Exchange now sits just above the 24,000-point plateau although it's likely to turn lower again on Friday.

RTTNews | 48 minutes ago

EURUSD	1.16614	GBPUSD	1.34393	AUDUSD	0.65174
USDJPY	147.284	USDCAD	1.37444	USDCHF	0.80707

Advertisement

Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223